Clinical Actual Use Human Factors Testing

Author(s):  
Shannon Clark ◽  
P.E., Denise Forkey

Due to perceived cost and time savings, medical device and combination product manufacturers frequently consider the option to combine human factors testing with clinical studies. There are some scenarios in which human factors and clinical testing of medical products can be combined to save time and resources. While guidance documents published by the Food and Drug Administration (FDA) emphasize that most human factors validation testing can fully evaluate use-related safety via simulated use usability testing, there are some cases in which clinical actual use usability testing is needed to fully evaluate use-related safety. This paper suggests synergies between clinical testing and human factors testing, presents challenges faced by human factors practitioners when the two types of testing are combined, and offers best practice recommendations to maximize the chance of successfully evaluating the human factors endpoints.

Author(s):  
Joshua Biro ◽  
David M. Neyens ◽  
Candace Jaruzel ◽  
Catherine D. Tobin ◽  
Myrtede Alfred ◽  
...  

Medication errors and error-related scenarios in anesthesia remain an important area of research. Interventions and best practice recommendations in anesthesia are often based in the work-as-imagined healthcare system, remaining under-used due to a range of unforeseen complexities in healthcare work-as- done. In order to design adaptable anesthesia medication delivery systems, a better understanding of clinical cognition within the context of anesthesia work is needed. Fourteen interviews probing anesthesia providers’ decision making were performed. The results revealed three overarching themes: (1) anesthesia providers find cases challenging when they have incomplete information, (2) decision-making begins with information seeking, and (3) attributes such as expertise, experience, and work environment influence anesthesia providers’ information seeking and synthesis of tasks. These themes and the context within this data help create a more realistic view of work-as-done and generate insights into what potential medication error reducing interventions should look to avoid and what they could help facilitate.


Author(s):  
David J. Gladstone ◽  
M. Patrice Lindsay ◽  
James Douketis ◽  
Eric E Smith ◽  
Dar Dowlatshahi ◽  
...  

Author(s):  
Elizabeth M. Perpetua ◽  
Kimberly A. Guibone ◽  
Patricia A. Keegan ◽  
Roseanne Palmer ◽  
Martina K. Speight ◽  
...  

2021 ◽  
Vol 1 ◽  
pp. 3199-3208
Author(s):  
Emanuel Balzan ◽  
Pierre Vella ◽  
Philip Farrugia ◽  
Edward Abela ◽  
Glenn Cassar ◽  
...  

AbstractResearch funded projects are often concerned with the development of proof-of-concept products. Consequently, activities related to verification and validation testing (VVT) are often not considered in depth, even though various design iterations are carried out to refine an idea. Furthermore, the introduction of additive manufacturing (AM) has facilitated, in particular, the development of bespoke medical products. End bespoke products, which will be used by relevant stakeholders (e.g. patients and clinicians) are fabricated with the same manufacturing technologies used during prototyping. As a result, the detailed design stage of products fabricated by AM is much shorter. Therefore, to improve the market-readiness of bespoke medical devices, testing must be integrated within the development from an early stage, allowing better planning of resources. To address these issues, in this paper, a comprehensive VVT framework is proposed for research projects, which lack a VVT infrastructure. The framework builds up on previous studies and methods utilised in industry to enable project key experts to capture risks as early as the concept design stage.


2008 ◽  
Vol 178 (11) ◽  
pp. 1418-1425 ◽  
Author(s):  
P. Lindsay ◽  
M. Bayley ◽  
A. McDonald ◽  
I. D. Graham ◽  
G. Warner ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document